Oncology & Cancer

Calculating leukemia progression

A new computational study published in the International Journal of Bioinformatics Research and Applications has shown how mutations that give rise to drug resistance occur in a form of cancer known as acute myeloid leukemia ...

Oncology & Cancer

Researchers define unique group of high-risk lymphoma patients

The goal for many cancer patients is to reach the five-year, disease-free mark, but new research from UR Medicine's Wilmot Cancer Institute suggests that two years might be a more practical survival goal for people with follicular ...

Oncology & Cancer

Scientists trace genomic evolution of high-risk leukemia

By genomic sequencing of leukemia cells from relapsed patients at different stages, scientists have discovered key details of how acute lymphoblastic leukemia (ALL) cells mutate to survive chemotherapy. These mutations enable ...

Pediatrics

New approach to childhood malnutrition may reduce relapses, deaths

Children treated for moderate acute malnutrition—a condition suffered by an estimated 35 million children worldwide—experience a disturbingly high rate of relapse and even death in the year following treatment and recovery.

Diseases, Conditions, Syndromes

A new way of improving tuberculosis treatment rejected

Tuberculosis kills 1.5 million people across the world every year. The existing treatment is effective but long. Many patients abandon it before completion, increasing the risk of a relapse and favouring the emergence of ...

page 15 from 30